VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded down 11.1% during mid-day trading on Friday . The stock traded as low as C$0.08 and last traded at C$0.08. 470,001 shares changed hands during trading, an increase of 330% from the average session volume of 109,238 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The company has a 50-day moving average price of C$0.10 and a 200-day moving average price of C$0.14. The firm has a market capitalization of C$12.98 million, a price-to-earnings ratio of -2.47 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- What is Put Option Volume?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- EV Stocks and How to Profit from Them
- DuPont’s Electronics Spinoff: The Start of Something Big
- Ride Out The Recession With These Dividend Kings
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
